ZYX and melanoma: Anti-PD-1 administration reduced the subcutaneous growth of melanoma-derived B16-F10 cells in Zyxin KO mice (Fig. 6I–K), with significantly more CD8+ T lymphocyte infiltration (Fig. EV6J).